70 related articles for article (PubMed ID: 38526631)
1. Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.
Wang WL; Jiang HJ; Shen ZL; Tang YL; Jiang J; Liang XH
Arch Oral Biol; 2024 Jul; 163():105982. PubMed ID: 38678878
[TBL] [Abstract][Full Text] [Related]
2. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38836761
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma.
Liu H; Ye Z; Wang X; Wu Y; Deng C
J Stomatol Oral Maxillofac Surg; 2024 Jun; ():101937. PubMed ID: 38844022
[TBL] [Abstract][Full Text] [Related]
4. Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
Zhang M; Sun Q; Han Z; Qin X; Gao T; Xu Y; Han S; Zhang Y; Liang Q; Guo Z; Liu J
Heliyon; 2024 May; 10(10):e30877. PubMed ID: 38774325
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing-based approaches to identifying disulfidptosis-related diagnostic clusters and immune landscapes in osteoporosis.
Zhang P; Li B; Chen H; Ge Z; Shang Q; Liang D; Yu X; Ren H; Jiang X; Cui J
Aging (Albany NY); 2024 May; 16(9):8198-8216. PubMed ID: 38738994
[TBL] [Abstract][Full Text] [Related]
6. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
[TBL] [Abstract][Full Text] [Related]
7. Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach.
Kut C; Midthune D; Lee E; Fair P; Cheunkarndee T; McNutt T; DeWeese T; Fakhry C; Kipnis V; Quon H
JCO Clin Cancer Inform; 2023 Sep; 7():e2300058. PubMed ID: 38096467
[TBL] [Abstract][Full Text] [Related]
8. Identification and Construction of a Disulfidptosis-Mediated Diagnostic Model and Associated Immune Microenvironment of Osteoarthritis from the Perspective of PPPM.
Hu K; Ou Y; Xiao L; Gu R; He F; Peng J; Shu Y; Li T; Hao L
J Inflamm Res; 2024; 17():3753-3770. PubMed ID: 38882183
[TBL] [Abstract][Full Text] [Related]
9. Developing Robust Predictive Models for Head and Neck Cancer across Microarray and RNA-seq Data.
Kaddi CD; Coulter WH; Wang MD
ACM BCB; 2015 Sep; 2015():393-402. PubMed ID: 29568818
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary screening of precision oncology biomarkers and its applications in prognostic model construction.
Zhang ZW; Zhang KX; Liao X; Quan Y; Zhang HY
iScience; 2024 Jun; 27(6):109859. PubMed ID: 38799582
[TBL] [Abstract][Full Text] [Related]
11. Author Correction: Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
Pan Y; Jin X; Xu H; Hong J; Li F; Luo T; Zeng J
Sci Rep; 2024 Jun; 14(1):13809. PubMed ID: 38877092
[No Abstract] [Full Text] [Related]
12. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel head and neck squamous cell carcinoma prognostic signature by bulk/single-cell sequencing data integration.
Dai Y; Li J; Huang R; Yao Q; Shi Y; Guo S; Wang Y; Cheng J
Oral Dis; 2024 Mar; 30(2):128-139. PubMed ID: 36398480
[TBL] [Abstract][Full Text] [Related]
14. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
[TBL] [Abstract][Full Text] [Related]
15. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC.
Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z
Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012
[TBL] [Abstract][Full Text] [Related]
16. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts.
Xue H; Sun Q; Zhang H; Huang H; Xue H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):156. PubMed ID: 38526631
[TBL] [Abstract][Full Text] [Related]
17. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y
Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]